Abstract
Contact lens type amniotic membrane (CLAM) is a promising new approach to using amniotic membrane in ophthalmology. It can be used to treat a range of ocular surface disorders, including dry eye disease, corneal ulcers, and chemical burns. CLAM can help to reduce inflammation, promote epithelialization and wound healing, and improve corneal clarity and vision. Its ease of handling and application, combined with its potential therapeutic benefits, make it an attractive option for treating a range of ocular surface diseases. However, further studies are needed to fully evaluate the safety and efficacy of CLAM, and to optimize its processing and application protocols.
Funder
National Research Foundation of Korea
Publisher
The Korean Optometry Society and The Korean Contact Lens Study Society